{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:56:14Z","timestamp":1794322574999,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Research Council of Norway, Global Health and Vaccination Research programme."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23209-x","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T03:50:38Z","timestamp":1749009038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The economic burden and catastrophic health expenditures among children with sickle cell anaemia on households in malaria-endemic areas: insights from Uganda and Malawi"],"prefix":"10.1186","volume":"25","author":[{"given":"Carol","family":"Kamya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Idro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Kalibbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamija S","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandile","family":"Nkosi-Gondwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Akun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanita","family":"Kirikumwino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddvar","family":"Kaarboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robberstad","family":"Bjarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"7","key":"23209_CR1","doi-asserted-by":"publisher","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484.","journal-title":"PLoS Med"},{"key":"23209_CR2","volume-title":"Man\u2019s haemoglobins, including the haemoglobinopathies and their investigation","author":"H Lehmann","year":"1974","unstructured":"Lehmann H, Huntsman RG. Man\u2019s haemoglobins, including the haemoglobinopathies and their investigation. Amsterdam, The Netherlands: North-Holland Publishing Company; 1974."},{"key":"23209_CR3","doi-asserted-by":"crossref","unstructured":"Patrick MT. Time to invest in sickle cell anemia as a global health priority. Pediatrics. 2016;137(6).","DOI":"10.1542\/peds.2016-0348"},{"key":"23209_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86:480\u20137.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"23209_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0168-8510(00)00105-6","volume":"54","author":"O Onwujekwe","year":"2000","unstructured":"Onwujekwe O, Chima R, Okonkwo P. Economic burden of malaria illness on households versus that of all other illness episodes: a study in five malaria holo-endemic Nigerian communities. Health Policy. 2000;54(2):143\u201359.","journal-title":"Health Policy"},{"issue":"10","key":"23209_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1365-3156.2007.01899.x","volume":"12","author":"MF Somi","year":"2007","unstructured":"Somi MF, Butler JR, Vahid F, Njau JD, Kachur SP, Abdulla S. Economic burden of malaria in rural Tanzania: variations by socioeconomic status and season. Tropical Med Int Health. 2007;12(10):1139\u201347.","journal-title":"Tropical Med Int Health"},{"key":"23209_CR7","unstructured":"Regional Committee for Africa 60. Sickle-Cell Disease: a strategy for the WHO African Region. 2011 May 26 [cited 2021 Feb 17]; Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/1682"},{"issue":"1","key":"23209_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/136485907X154638","volume":"101","author":"J Makani","year":"2007","unstructured":"Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: burden and research priorities. Annals Trop Med Parasitol. 2007;101(1):3\u201314.","journal-title":"Annals Trop Med Parasitol"},{"issue":"7","key":"23209_CR9","first-page":"384","volume":"80","author":"GR Serjeant","year":"2003","unstructured":"Serjeant GR, Ndugwa CM. Sickle cell disease in Uganda: a time for action. East Afr Med J. 2003;80(7):384\u20137.","journal-title":"East Afr Med J"},{"key":"23209_CR10","unstructured":"World Health Organisation. World malaria report 2020: 20 years of global progress and challenges. Geneva. [Internet]. 2020 [cited 2021 Jun 24]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240015791"},{"issue":"1","key":"23209_CR11","first-page":"40","volume":"112","author":"H Davis","year":"1997","unstructured":"Davis H, Moore RM Jr, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the united States. Public Health Rep. 1997;112(1):40.","journal-title":"Public Health Rep"},{"issue":"6","key":"23209_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ajh.21408","volume":"84","author":"TL Kauf","year":"2009","unstructured":"Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84(6):323\u20137.","journal-title":"Am J Hematol"},{"key":"23209_CR13","unstructured":"Okorosobo T, Okorosobo F, Mwabu G, Orem JN, Kirigia JM. Economic burden of malaria in six countries of Africa. 2011."},{"issue":"4","key":"23209_CR14","doi-asserted-by":"publisher","first-page":"S550","DOI":"10.1016\/j.amepre.2010.01.004","volume":"38","author":"DD Amendah","year":"2010","unstructured":"Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease\u2013related pediatric medical expenditures in the US. Am J Prev Med. 2010;38(4):S550\u20136.","journal-title":"Am J Prev Med"},{"issue":"4","key":"23209_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/pbc.22069","volume":"53","author":"M Mvundura","year":"2009","unstructured":"Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the united States. Pediatr Blood Cancer. 2009;53(4):642\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"23209_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/CEOR.S86599","volume":"7","author":"OS Olatunya","year":"2015","unstructured":"Olatunya OS, Ogundare EO, Fadare JO, Oluwayemi IO, Agaja OT, Adeyefa BS, et al. The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria. Clinicoecon Outcomes Res. 2015;7:545\u201353.","journal-title":"Clinicoecon Outcomes Res"},{"key":"23209_CR17","unstructured":"World Health Organization. Designing health financing systems to reduce catastrophic health expenditure. [Internet]. World Health Organization, Department of Health Systems Financing, Health Financing Policy; 2005 [cited 2021 Sep 21]. Available from: https:\/\/www.who.int\/health_financing\/pb_2.pdf"},{"key":"23209_CR18","unstructured":"Xu K. Distribution of health payments and catastrophic expenditures methodology. In: Distribution of health payments and catastrophic expenditures Methodology. 2005."},{"issue":"9378","key":"23209_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0140-6736(03)13861-5","volume":"362","author":"K Xu","year":"2003","unstructured":"Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362(9378):111\u20137.","journal-title":"Lancet"},{"issue":"1","key":"23209_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.healthpol.2013.10.001","volume":"115","author":"C Kronenberg","year":"2014","unstructured":"Kronenberg C, Barros PP. Catastrophic healthcare expenditure\u2013drivers and protection: the Portuguese case. Health Policy. 2014;115(1):44\u201351.","journal-title":"Health Policy"},{"key":"23209_CR21","unstructured":"Murray CJ. Understanding household catastrophic health expenditures: a Multi-country analysis. Health Syst Perform Assess:565."},{"issue":"11","key":"23209_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1182\/blood.V110.11.958.958","volume":"110","author":"AG Hartzema","year":"2007","unstructured":"Hartzema AG, Kauf TL, Coates TD, Huazhi L, Mody-Patel N. Economic burden of sickle cell disease among children and adults. Blood. 2007;110(11):958.","journal-title":"Blood"},{"issue":"8","key":"23209_CR23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jval.2021.02.014","volume":"24","author":"D Holdford","year":"2021","unstructured":"Holdford D, Vendetti N, Sop DM, Johnson S, Smith WR. Indirect economic burden of sickle cell disease. Value Health. 2021;24(8):1095\u2013101.","journal-title":"Value Health"},{"key":"23209_CR24","doi-asserted-by":"crossref","unstructured":"Lee S, Vania DK, Bhor M, Revicki D, Abogunrin S, Sarri G. Patient-reported outcomes and economic burden of adults with sickle cell disease in the united States: a systematic review. Int J Gen Med. 2020;361\u201377.","DOI":"10.2147\/IJGM.S257340"},{"issue":"8","key":"23209_CR25","doi-asserted-by":"publisher","first-page":"e0272491","DOI":"10.1371\/journal.pone.0272491","volume":"17","author":"CN Amarachukwu","year":"2022","unstructured":"Amarachukwu CN, Okoronkwo IL, Nweke MC, Ukwuoma MK. Economic burden and catastrophic cost among people living with sickle cell disease, attending a tertiary health institution in south-east zone. Nigeria Plos One. 2022;17(8):e0272491.","journal-title":"Nigeria Plos One"},{"issue":"1","key":"23209_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-023-07274-4","volume":"24","author":"T Nkosi-Gondwe","year":"2023","unstructured":"Nkosi-Gondwe T, Robberstad B, Opoka R, Kalibbala D, Rujumba J, Galileya LT, et al. Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in Eastern and Southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial. Trials. 2023;24(1):1\u201314.","journal-title":"Trials"},{"issue":"3","key":"23209_CR27","doi-asserted-by":"publisher","first-page":"e01818","DOI":"10.1128\/AAC.01818-18","volume":"63","author":"V Asua","year":"2019","unstructured":"Asua V, Vinden J, Conrad MD, Legac J, Kigozi SP, Kamya MR, et al. Changing molecular markers of antimalarial drug sensitivity across Uganda. Antimicrob Agents Chemother. 2019;63(3):e01818\u201318.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"23209_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","volume":"20","author":"C Jo","year":"2014","unstructured":"Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327.","journal-title":"Clin Mol Hepatol"},{"key":"23209_CR29","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford University Press; 2015."},{"key":"23209_CR30","unstructured":"Uganda Bureau of Statistics. Annual Labour Force Survey 2018\/19 Main Report [Internet]. 2019 [cited 2022 Aug 17]. Available from: https:\/\/www.ubos.org\/wp-content\/uploads\/publications\/05_20212018-19_ALFS_Report_FINAL.pdf"},{"key":"23209_CR31","unstructured":"Danish Trade Union Development Agency. Labour Market Profile Malawi\u2013 2022 [Internet]. [cited 2023 Nov 4]. Available from: https:\/\/www.ulandssekretariatet.dk\/wp-content\/uploads\/2022\/03\/LMP-Malawi-2022-Final1.pdf"},{"issue":"9","key":"23209_CR32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jval.2019.03.021","volume":"22","author":"HC Turner","year":"2019","unstructured":"Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for inflation and currency changes within health economic studies. Value Health. 2019;22(9):1026\u201332.","journal-title":"Value Health"},{"key":"23209_CR33","unstructured":"World Bank. GDP deflator| Data [Internet]. [cited 2022 Aug 17]. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.DEFL.ZS"},{"issue":"6","key":"23209_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/heapol\/czl029","volume":"21","author":"S Vyas","year":"2006","unstructured":"Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plann. 2006;21(6):459\u201368.","journal-title":"Health Policy Plann"},{"key":"23209_CR35","doi-asserted-by":"crossref","unstructured":"Davino C, Furno M, Vistocco D. Quantile regression: theory and applications. Volume 988. Wiley; 2013.","DOI":"10.1002\/9781118752685"},{"issue":"1","key":"23209_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-015-0168-9","volume":"14","author":"S Buigut","year":"2015","unstructured":"Buigut S, Ettarh R, Amendah DD. Catastrophic health expenditure and its determinants in Kenya slum communities. Int J Equity Health. 2015;14(1):1\u201312.","journal-title":"Int J Equity Health"},{"issue":"1","key":"23209_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12962-023-00457-5","volume":"21","author":"HA Nguyen","year":"2023","unstructured":"Nguyen HA, Ahmed S, Turner HC. Overview of the main methods used for estimating catastrophic health expenditure. Cost Eff Resource Allocation. 2023;21(1):50.","journal-title":"Cost Eff Resource Allocation"},{"issue":"1","key":"23209_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-12-413","volume":"12","author":"J Chuma","year":"2012","unstructured":"Chuma J, Maina T. Catastrophic health care spending and impoverishment in Kenya. BMC Health Serv Res. 2012;12(1):1\u20139.","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"23209_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/hec.776","volume":"12","author":"A Wagstaff","year":"2003","unstructured":"Wagstaff A, van Doorslaer E. Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993\u20131998. Health Econ. 2003;12(11):921\u201333.","journal-title":"Health Econ"},{"key":"23209_CR40","volume-title":"StataCorp Stata statistical software: release 14","author":"LP StataCorp","year":"2015","unstructured":"StataCorp LP. StataCorp Stata statistical software: release 14. College Station, TX, USA: StataCorp LP; 2015."},{"issue":"1","key":"23209_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force. Value Health. 2022;25(1):10\u201331.","journal-title":"Value Health"},{"issue":"4","key":"23209_CR42","doi-asserted-by":"publisher","first-page":"e61130","DOI":"10.1371\/journal.pone.0061130","volume":"8","author":"DD Amendah","year":"2013","unstructured":"Amendah DD, Mukamah G, Komba A, Ndila C, Williams TN. Routine paediatric sickle cell disease (SCD) outpatient care in a rural Kenyan hospital: utilization and costs. PLoS ONE. 2013;8(4):e61130.","journal-title":"PLoS ONE"},{"issue":"suppl2","key":"23209_CR43","first-page":"ii41","volume":"26","author":"J Nabyonga Orem","year":"2011","unstructured":"Nabyonga Orem J, Mugisha F, Kirunga C, Macq J, Criel B. Abolition of user fees: the Uganda paradox. Health Policy Plann. 2011;26(suppl2):ii41\u201351.","journal-title":"Health Policy Plann"},{"issue":"1","key":"23209_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1468-2397.2010.00771.x","volume":"21","author":"JM Twikirize","year":"2012","unstructured":"Twikirize JM, O\u2019Brien C. Why Ugandan rural households are opting to pay community health insurance rather than use the free healthcare services. Int J Social Welf. 2012;21(1):66\u201378.","journal-title":"Int J Social Welf"},{"key":"23209_CR45","unstructured":"Zikusooka CM, Kyomuhang R, Orem JN, Tumwine M. Is health care financing in Uganda equitable? Afr Health Sci. 2009;9(2)."},{"issue":"2","key":"23209_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/pbc.24176","volume":"59","author":"JA Panepinto","year":"2012","unstructured":"Panepinto JA, Bonner M. Health-related quality of life in sickle cell disease: past, present, and future. Pediatr Blood Cancer. 2012;59(2):377\u201385.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"23209_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-4-59","volume":"4","author":"SK Ballas","year":"2006","unstructured":"Ballas SK, Barton FB, Waclawiw MA, Swerdlow P, Eckman JR, Pegelow CH, et al. Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes. 2006;4(1):1\u20138.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"23209_CR48","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1542\/peds.2008-0441","volume":"122","author":"JJ Strouse","year":"2008","unstructured":"Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, et al. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics. 2008;122(6):1332\u201342.","journal-title":"Pediatrics"},{"issue":"6","key":"23209_CR49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1108\/IJHCQA-01-2013-0008","volume":"27","author":"E Nwenyi","year":"2014","unstructured":"Nwenyi E, Leafman J, Mathieson K, Ezeobah N. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not. Int J Health Care Qual Assur. 2014;27(6):468\u201381.","journal-title":"Int J Health Care Qual Assur"},{"issue":"24","key":"23209_CR50","first-page":"2585","volume":"130","author":"RO Opoka","year":"2017","unstructured":"Opoka RO, Ndugwa CM, Latham TS, Lane A, Hume HA, Kasirye P, et al. Novel use of hydroxyurea in an African region with malaria (NOHARM): a trial for children with sickle cell anemia. Blood J Am Soc Hematol. 2017;130(24):2585\u201393.","journal-title":"Blood J Am Soc Hematol"},{"issue":"26","key":"23209_CR51","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","volume":"382","author":"CC John","year":"2020","unstructured":"John CC, Opoka RO, Latham TS, Hume HA, Nabaggala C, Kasirye P, et al. Hydroxyurea dose escalation for sickle cell anemia in Sub-Saharan Africa. N Engl J Med. 2020;382(26):2524\u201333.","journal-title":"N Engl J Med"},{"issue":"11","key":"23209_CR52","doi-asserted-by":"publisher","first-page":"e27954","DOI":"10.1002\/pbc.27954","volume":"66","author":"T Mvalo","year":"2019","unstructured":"Mvalo T, Topazian HM, Kamthunzi P, Chen JS, Kambalame I, Mafunga P, et al. Real-world experience using hydroxyurea in children with sickle cell disease in Lilongwe. Malawi Pediatr Blood cancer. 2019;66(11):e27954.","journal-title":"Malawi Pediatr Blood cancer"},{"key":"23209_CR53","volume-title":"Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges","author":"D Dexter","year":"2023","unstructured":"Dexter D, McGann PT. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy; 2023."},{"key":"23209_CR54","doi-asserted-by":"crossref","unstructured":"Idro R, Nkosi-Gondwe T, Opoka RO, Ssenkusu JM, Kalibbala DM, Tsirizani L et al. Weekly Dihydroartemisinin-Piperaquine Versus Monthly Sulphadoxine-Pyrimethamine for Malaria Chemoprevention in Children with Sickle Cell Anaemia in Uganda and Malawi: A Randomised, Double-Blind, Placebo-Controlled Trial (Chemcha). 2024 May 29 [cited 2025 Jan 18]; Available from: https:\/\/papers.ssrn.com\/abstract=4835839","DOI":"10.2139\/ssrn.4835839"},{"issue":"1","key":"23209_CR55","doi-asserted-by":"publisher","first-page":"e83428","DOI":"10.1371\/journal.pone.0083428","volume":"9","author":"DD Amendah","year":"2014","unstructured":"Amendah DD, Buigut S, Mohamed S. Coping strategies among urban poor: evidence from Nairobi, Kenya. PLoS ONE. 2014;9(1):e83428.","journal-title":"PLoS ONE"},{"issue":"1","key":"23209_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/pbc.20792","volume":"48","author":"JT Moskowitz","year":"2007","unstructured":"Moskowitz JT, Butensky E, Harmatz P, Vichinsky E, Heyman MB, Acree M, et al. Caregiving time in sickle cell disease: psychological effects in maternal caregivers. Pediatr Blood Cancer. 2007;48(1):64\u201371.","journal-title":"Pediatr Blood Cancer"},{"key":"23209_CR57","unstructured":"OKANY CC, AKINYANJU OO. The influence of socio-economic status on the severity of sickle cell disease. 1993."},{"issue":"7","key":"23209_CR58","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.sjbs.2020.03.008","volume":"27","author":"SA Khan","year":"2020","unstructured":"Khan SA, AlSiny F, Makki A, Ali A, AlAnsari I, Khan S. Socioeconomic status dependent medical complexities in children with sickle cell disease in Saudi Arabia. Saudi J Biol Sci. 2020;27(7):1781\u20137.","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"23209_CR59","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/1119-3077.91748","volume":"14","author":"BA Animasahun","year":"2011","unstructured":"Animasahun BA, Temiye EO, Ogunkunle OO, Izuora AN, Njokanma OF. The influence of socioeconomic status on the hemoglobin level and anthropometry of sickle cell anemia patients in steady state at the Lagos university teaching hospital. Niger J Clin Pract. 2011;14(4):422\u20137.","journal-title":"Niger J Clin Pract"},{"issue":"1","key":"23209_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-016-0257-4","volume":"42","author":"CI Esezobor","year":"2016","unstructured":"Esezobor CI, Akintan P, Akinsulie A, Temiye E, Adeyemo T. Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos, Nigeria. Ital J Pediatr. 2016;42(1):1\u20138.","journal-title":"Ital J Pediatr"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23209-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:02:07Z","timestamp":1749013327000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23209-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23209"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23209-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained ethical approval from the Makerere University School of Medicine Research and Ethics Committee (SOMREC 2020\u2009\u2212\u2009103), the Uganda National Council of Science and Technology (UNCST HS709ES), the National Health Science Research Committee in Malawi (19\/11\/2442), the Regional Ethics Committee of Norway (REK 30992), and the Liverpool School of Tropical Medicine (LSTM REC 19\u2013105) institutional review boards. Permission was obtained from the hospitals where the study was conducted. Informed consent was obtained from all the study participants and from their parents or legal guardians involved in the study. The study staff used consent forms in English or the local languages. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2070"}}